Cargando…

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

Despite extensive global efforts in the fight against killer infectious diseases, they still cause one in four deaths worldwide and are important causes of long-term functional disability arising from tissue damage. The continuing epidemics of tuberculosis, HIV, malaria, and influenza, and the emerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zumla, Alimuddin, Rao, Martin, Wallis, Robert S, Kaufmann, Stefan H E, Rustomjee, Roxana, Mwaba, Peter, Vilaplana, Cris, Yeboah-Manu, Dorothy, Chakaya, Jeremiah, Ippolito, Giuseppe, Azhar, Esam, Hoelscher, Michael, Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164794/ https://www.ncbi.nlm.nih.gov/pubmed/27036359 http://dx.doi.org/10.1016/S1473-3099(16)00078-5

Ejemplares similares

Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region
por: Ntoumi, Francine, et al.
Publicado: (2016)

Middle East Respiratory Syndrome - need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa
por: Zumla, Alimuddin, et al.
Publicado: (2015)

Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.
por: Ntoumi, Francine, et al.
Publicado: (2022)

Delamanid expanded access novel treatment of drug resistant tuberculosis
por: Rustomjee, Roxana, et al.
Publicado: (2015)

Reducing mortality from 2019-nCoV: host-directed therapies should be an option
por: Zumla, Alimuddin, et al.
Publicado: (2020)

Zoonotic Tuberculosis – The Changing Landscape
por: Kock, Richard, et al.
Publicado: (2021)

World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis
por: Ntoumi, Francine, et al.
Publicado: (2022)

Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections
por: Zumla, Alimuddin, et al.
Publicado: (2015)

Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base
por: Nachega, Jean B., et al.
Publicado: (2021)

The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
por: Azhar, Esam I., et al.
Publicado: (2016)

Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
por: Rao, Martin, et al.
Publicado: (2019)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV)
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa – A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic()
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2022)

Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia
por: Azhar, Esam I., et al.
Publicado: (2016)

Rapid diagnostics urgently needed for killer infections
por: Zumla, Alimuddin, et al.
Publicado: (2013)

Toning down the 2019-nCoV media hype—and restoring hope
por: Ippolito, Giuseppe, et al.
Publicado: (2020)

World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic
por: Petersen, Eskild, et al.
Publicado: (2022)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
por: Kroesen, Vera M., et al.
Publicado: (2017)

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB
por: Chakaya, Jeremiah, et al.
Publicado: (2022)

Burden of respiratory tract infections at post mortem in Zambian children
por: Bates, Matthew, et al.
Publicado: (2016)

Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review
por: Wallis, Robert S., et al.
Publicado: (2016)

Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Mandell, Douglas, and Bennett's principles and practice of infectious diseases
por: Zumla, Alimuddin
Publicado: (2010)

Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2
por: Hui, David S., et al.
Publicado: (2022)

Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
por: Ramalho, Renata, et al.
Publicado: (2020)

Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants
por: de Sousa, Eric, et al.
Publicado: (2020)

T-Cell Therapy: Options for Infectious Diseases
por: Parida, Shreemanta K., et al.
Publicado: (2015)

COVID-19 and the scaled-down 2020 Hajj Pilgrimage—Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns
por: Zumla, Alimuddin, et al.
Publicado: (2020)

WITHDRAWN: ‘COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns’
por: Zumla, Alimuddin, et al.
Publicado: (2020)

Confronting the persisting threat of the Middle East respiratory syndrome to global health security
por: Perlman, Stanley, et al.
Publicado: (2020)

The challenges of cholera at the 2017 Hajj pilgrimage
por: Zumla, Alimuddin, et al.
Publicado: (2017)

Emerging and Reemerging Infectious Diseases: Global Overview
por: Zumla, Alimuddin, et al.
Publicado: (2019)

Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia
por: Bates, Matthew, et al.
Publicado: (2013)

Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
por: Zumla, Alimuddin, et al.
Publicado: (2014)

Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients
por: Bates, Matthew, et al.
Publicado: (2012)

The Middle East Respiratory Syndrome (MERS)
por: Azhar, Esam I., et al.
Publicado: (2019)

COVID-19—Zoonosis or Emerging Infectious Disease?
por: Haider, Najmul, et al.
Publicado: (2020)

Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa
por: Nachega, Jean B., et al.
Publicado: (2021)

Coronaviruses — drug discovery and therapeutic options
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2lap4p4enpato14kb4apksqtvd